FDA
approval
· 2015-07-20
FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
The FDA approved Teva's supplemental application for CLARAVIS (isotretinoin), enhancing the product's approved labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CLARAVIS (ISOTRETINOIN)